Health

Emerging research reveals that the hundreds of bacterial species colonizing your mouth may influence conditions far beyond dental health, from cardiovascular disease to cancer.

New real-world data shows biologic therapies dramatically reduce severe asthma exacerbations in children, with the strongest benefits seen when treatment begins earlier in life.

Researchers have demonstrated that transplanted neural stem cells can help preserve vision in models of retinal degeneration, offering a potential treatment pathway for conditions that currently have no cure.

After years of development challenges, oral GLP-1 weight loss drugs are finally hitting the market. Novo Nordisk's oral Wegovy is already available, with Eli Lilly's orforglipron expected to win FDA approval soon.

Vinay Prasad, a controversial figure at the FDA's biologics center and key ally of Commissioner Makary, is leaving the agency.

Pfizer has won approval for a GLP-1 obesity drug in China shortly after licensing the shot from Hangzhou-based Sciwind Biosciences.

Eli Lilly launches a program to make it easier for employers to add GLP-1 weight loss and diabetes drugs to their health plans, addressing a major coverage gap.

The FDA unveils a new retention bonus program aimed at keeping experienced drug reviewers as the agency faces mounting workforce challenges.

Prime Medicine reverses course to seek FDA approval for a previously sidelined rare immune disease therapy, citing the agency's evolving stance on rare diseases.

Moderna agrees to pay $950 million to settle long-running patent claims with Arbutus and Roivant over lipid nanoparticle technology used in its COVID vaccine.

An 'off-the-shelf' neoantigen vaccine has demonstrated safety and immunogenicity in individuals with Lynch syndrome, a hereditary condition that dramatically increases cancer risk. The results advance the prospect of preventive cancer vaccines for people with genetic predispositions.

A new study published in Nature Medicine evaluates ChatGPT's performance in making triage recommendations using structured clinical scenarios. The findings offer one of the most rigorous assessments yet of whether large language models can reliably assist in medical decision-making.

Pharmaceutical giant GSK has agreed to buy 35Pharma, a biotech focused on pulmonary hypertension, for $950 million. The deal expands GSK's respiratory and cardiovascular portfolio with a pipeline targeting a disease that currently has limited treatment options.

Polymer nanoparticle startup BreezeBio has raised $60 million to advance an mRNA-based therapy for diabetes that uses novel delivery technology to target pancreatic cells. The approach could offer a fundamentally different treatment paradigm for the hundreds of millions living with the disease.

A growing body of research suggests that the shingles vaccine does more than prevent a painful rash — it may significantly reduce the risk of dementia, including Alzheimer's disease, and even slow biological aging. The latest studies add to evidence that has been accumulating for years.

Dr. Casey Means, a prominent figure in the Make America Healthy Again movement, appeared before the Senate for her confirmation hearing as the nation's next Surgeon General. The Stanford-trained physician has championed metabolic health reform while drawing scrutiny for her unconventional medical views.

Novo Nordisk has struck a deal with Vivtex, a biotech co-founded by MIT professor Robert Langer, to develop oral versions of obesity and diabetes treatments. The partnership could eliminate the need for weekly injections that have defined the GLP-1 drug revolution.

A breakthrough discovery from researchers at the University of Colorado Anschutz is reshaping how medical professionals approach patient care in the aftermath of traumatic injury. According to find...

Researchers have identified a potentially critical mechanism by which abnormal lung tissue manages to escape the body's natural immune defenses, a discovery that could reshape how medical professio...

Asthma represents one of the most prevalent chronic respiratory conditions globally, yet its impact falls unevenly across populations. Adult women suffer from asthma at significantly higher rates t...